© Synapse Social LLC, 2026
October 1, 2024
Figure S12 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer AC Anran Chen Shanghai Jiao Tong University BK Beom-Jun Kim Baylor College of Medicine AM Aparna Mitra Baylor College of Medicine
See all Key Points Key points are not available for this paper at this time.
Abstract Synergy and viability analysis of AZD1775 and gemcitabine combination in T47D parental and Palbo-R cells
Figure S12 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer | Synapse
Chen et al. (Tue,) studied this question.
2
Figure S13 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER<sup>+</sup> Breast Cancer 2024